In addition, a statistical trend toward higher CV risk was observed for individuals in the T1 of FGF19 concentrations compared to those in T3 [27.70 ± 20.79 vs. 47.74 ± 26.87 months, HR = 1.73 (0.86–3.47), p = 0.123].
← all excerpts
Combined concentrations and genetic variability of fibroblast growth factors predict cardiovascular risk in renal patients.
1
—
—